中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2010年
12期
1621-1622
,共2页
徐琪%单黎丽%宁彬%董西学%刘伟%阳海红
徐琪%單黎麗%寧彬%董西學%劉偉%暘海紅
서기%단려려%저빈%동서학%류위%양해홍
冠状动脉疾病%支架%西罗莫司
冠狀動脈疾病%支架%西囉莫司
관상동맥질병%지가%서라막사
Coronary disease%Stent%Sirolimus
目的 探讨国产西罗莫司药物洗脱支架在老年冠心病患者中应用的疗效和安全性.方法 对在该院接受国产西罗莫司药物洗脱支架Firebird治疗的107例老年冠心病患者,观察术后即刻效果、住院期间并发症及6个月随访结果.结果 成功植入175个Firebird支架,支架植入即刻成功率98.9%,住院期间支架内血栓1例(0.9%)致死亡,随访6个月,无心肌梗死、死亡发生,复发心绞痛6例,支架再狭窄发生率为2.6%,6个月主要心脏不良事件(MACE)发生率为2.8%.结论 老年冠心病患者应用国产西罗莫司药物洗脱支架安全有效.
目的 探討國產西囉莫司藥物洗脫支架在老年冠心病患者中應用的療效和安全性.方法 對在該院接受國產西囉莫司藥物洗脫支架Firebird治療的107例老年冠心病患者,觀察術後即刻效果、住院期間併髮癥及6箇月隨訪結果.結果 成功植入175箇Firebird支架,支架植入即刻成功率98.9%,住院期間支架內血栓1例(0.9%)緻死亡,隨訪6箇月,無心肌梗死、死亡髮生,複髮心絞痛6例,支架再狹窄髮生率為2.6%,6箇月主要心髒不良事件(MACE)髮生率為2.8%.結論 老年冠心病患者應用國產西囉莫司藥物洗脫支架安全有效.
목적 탐토국산서라막사약물세탈지가재노년관심병환자중응용적료효화안전성.방법 대재해원접수국산서라막사약물세탈지가Firebird치료적107례노년관심병환자,관찰술후즉각효과、주원기간병발증급6개월수방결과.결과 성공식입175개Firebird지가,지가식입즉각성공솔98.9%,주원기간지가내혈전1례(0.9%)치사망,수방6개월,무심기경사、사망발생,복발심교통6례,지가재협착발생솔위2.6%,6개월주요심장불량사건(MACE)발생솔위2.8%.결론 노년관심병환자응용국산서라막사약물세탈지가안전유효.
Objective To observe the effects and security of rapamycin drug-eluting stents implanting in eld-eay patients with coronary heart disease(CHD).Methods 107 patients with CHD treated with Firebird rapamycin drug-eluting stents,the immediate angiographic outcome,complication in hospitalization.six months'follow-up results were assessed.Results 175 Firebird stents implanted successfully,the successful stenting procedure achieved in 98.9% patients,1 patient(0.9%) died of thrombosis instent during hospitalization.there were no myocardial infarction occurred during six months'follow-up,angina recrudesced in 6 patients,and the ratio of instent restenosis was 2.6%,the MACE rate during 6 months follow-up was 2.8%.Conclusion Firebird rapamycin drug-eluting stents implanta-tion in CHD in elderly was safe and effective.